What is the ticker symbol for Virios Therapeutics?

Virios Therapeutics trades under the ticker VIRI on NASDAQ.

What sector does Virios Therapeutics operate in?

Virios Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VIRI in a portfolio?

PortView shows VIRI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Virios Therapeutics (VIRI) Stock Analysis

NASDAQHealthcareBiotechnology

$0.16+12.40%

1-year price historyRange $2.83 – $21.00

52-week range$0.16

$0.14$26.00

What Virios Therapeutics does

Virios Therapeutics, Inc. is a biotechnology firm in its development phase, dedicated to pioneering antiviral treatments for conditions that arise from an unusual immune response triggered by viral infections. Its primary investigational compound, IMC-1, is a precisely formulated blend of famciclovir and celecoxib, currently being developed to address fibromyalgia. Additionally, the company is advancing IMC-2, a therapeutic combination of valacyclovir and celecoxib, aimed at mitigating the various long COVID symptoms, including ongoing fatigue, sleep disturbances, cognitive challenges, pain, autonomic dysfunction, and anxiety. Founded in 2012, the organization was initially known as Virios Therapeutics, LLC, before officially changing its name to Virios Therapeutics, Inc. in December 2020. The company's headquarters are located in Alpharetta, Georgia.

Key metrics

Market cap

$206,502

P/E (TTM)

-0.03

EPS (TTM)

$-5.75

Beta

1.58

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$4.51

200-day avg

$7.69

52-week high

$26.00

52-week low

$0.14

CEO

Gregory Duncan

ETFs linked to VIRI

Broad-market and Healthcare sector ETFs an investor holding Virios Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VIRI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VIRI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Virios Therapeutics?: Virios Therapeutics trades under the ticker VIRI on NASDAQ.
Which exchange is VIRI listed on?: VIRI is listed on NASDAQ.
What sector does Virios Therapeutics operate in?: Virios Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VIRI in a portfolio?: PortView shows VIRI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.